Ranimustine

Ranimustine

SCHEMBL10079210

CO[C@H]1OC(CNC(=O)N(CCCl)N=O)[C@@H](O)C(O)C1O

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
BLM P54132 2/20 0.46
PMP22 Q01453 2/20 0.46
MEN1 O00255 1/20 0.46
ABCB11 O95342 1/20 0.46
GSR P00390 1/20 0.46
TSHR P16473 1/20 0.46
HTT P42858 1/20 0.46
KMT2A Q03164 1/20 0.46
CA1 P00915 4/20 0.43
CA2 P00918 4/20 0.43
CA9 Q16790 4/20 0.43
G6PD P11413 3/20 0.41
ADRA2A P08913 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PDE4A P27815 1/20 0.39
ADRA1A P35348 1/20 0.39
MMP9 P14780 1/20 0.38
MMP12 P39900 1/20 0.38
LGALS8 O00214 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ranimustine SCHEMBL1650173 1.00 ALDH1A1 (0.46) ALDH1A1BLMPMP22MEN1ABCB11
Ranimustine SCHEMBL11757182 1.00 ALDH1A1 (0.46) ALDH1A1BLMPMP22MEN1ABCB11
Ranimustine SCHEMBL6429694 1.00 ALDH1A1 (0.46) ALDH1A1BLMPMP22MEN1ABCB11
Ranimustine SCHEMBL8333 1.00 ALDH1A1 (0.46) ALDH1A1BLMPMP22MEN1ABCB11
Ranimustine SCHEMBL15474340 1.00 ALDH1A1 (0.46) ALDH1A1BLMPMP22MEN1ABCB11
Ranimustine SCHEMBL22595035 1.00 ALDH1A1 (0.46) ALDH1A1BLMPMP22MEN1ABCB11
Ranimustine SCHEMBL5506489 0.90 ADRA2A (0.58) ALDH1A1BLMPMP22MEN1ABCB11
SCHEMBL17524415 0.89 CA1 (0.44) CA1CA2CA9G6PDMMP9
Ranimustine SCHEMBL2678774 0.89 PYGB (0.44) ALDH1A1BLMPMP22MEN1ABCB11
Ranimustine SCHEMBL4197596 0.89 ALDH1A1 (0.37) ALDH1A1BLMPMP22MEN1ABCB11

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10034851-B2 Metal-salen complex compound, local anesthetic and antineoplastic drug IHI CORPORATION (JP) 2018-07-31 US disclosed
US-20120029167-A1 AUTO MAGNETIC METAL SALEN COMPLEX COMPOUND YOSHIHIRO ISHIKAWA (JP) 2012-02-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120029167-A1 AUTO MAGNETIC METAL SALEN COMPLEX COMPOUND SDHB, SDHA, SLC40A1 ALDH1A1 2998/4885BLM 3136/4885PMP22 41/4885
US-10034851-B2 Metal-salen complex compound, local anesthetic and antineoplastic drug NCLN, KCNN2, NCSTN ALDH1A1 1531/4885BLM 2942/4885PMP22 2106/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.